{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:35:45Z","timestamp":1780104945577,"version":"3.54.0"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11,15]]},"DOI":"10.1093\/infdis\/jix360","type":"journal-article","created":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T19:11:52Z","timestamp":1500923512000},"page":"926-928","source":"Crossref","is-referenced-by-count":11,"title":["Adoptive Immunotherapy of Viral Infections: Should Infectious Disease Embrace Cellular Immunotherapy?"],"prefix":"10.1093","volume":"216","author":[{"given":"Michael","family":"Boeckh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Corey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,9,23]]},"reference":[{"key":"key\n\t\t\t\t20171115102728_CIT0001","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/cpt.392","article-title":"CD19-Targeted chimeric antigen receptor-modified T-cell immunotherapy for B-cell malignancies","volume":"100","year":"2016","journal-title":"Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t20171115102728_CIT0002","volume-title":"Oncologic Drugs Advisory Committee briefing document: tisagenlecleucel (CTL019) for the treatment of pediatric and young adult patients with relapsed\/refractory B-cell acute lymphoblastic leukemia","author":"Committee FA","year":"2017"},{"key":"key\n\t\t\t\t20171115102728_CIT0003","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM199510193331603","article-title":"Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor","volume":"333","year":"1995","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171115102728_CIT0004","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000072463","article-title":"Adoptive T-cell therapy for EBV-associated post-transplant lymphoproliferative disease","volume":"110","year":"2003","journal-title":"Acta Haematol"},{"key":"key\n\t\t\t\t20171115102728_CIT0005","doi-asserted-by":"crossref","first-page":"759","DOI":"10.12688\/f1000research.11164.1","article-title":"Novel approaches to HIV therapy","volume":"6","year":"2017","journal-title":"F1000Res"},{"key":"key\n\t\t\t\t20171115102728_CIT0006","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00102-15","article-title":"Approved antiviral drugs over the past 50 years","volume":"29","year":"2016","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20171115102728_CIT0007","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1309533","article-title":"Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation","volume":"370","author":"AIC246 Study Team","year":"2014","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171115102728_CIT0008","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2217\/imt.14.99","article-title":"Cytomegalovirus-specific T-cell therapies: current status and future prospects","volume":"7","year":"2015","journal-title":"Immunotherapy"},{"key":"key\n\t\t\t\t20171115102728_CIT0009","doi-asserted-by":"crossref","first-page":"242ra83","DOI":"10.1126\/scitranslmed.3008825","article-title":"Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT","volume":"6","year":"2014","journal-title":"Sci Transl Med"},{"key":"key\n\t\t\t\t20171115102728_CIT0010","article-title":"Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT [manuscript published online ahead of print 17 February 2017]","year":"2017","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20171115102728_CIT0011","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.jaci.2015.12.1311","article-title":"Adoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytes","volume":"137","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"key\n\t\t\t\t20171115102728_CIT0012","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1038\/mt.2013.151","article-title":"Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant","volume":"21","year":"2013","journal-title":"Mol Ther"},{"key":"key\n\t\t\t\t20171115102728_CIT0013","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.bbmt.2008.11.029","article-title":"Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies","volume":"15","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"key\n\t\t\t\t20171115102728_CIT0014","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1182\/blood-2013-02-486324","article-title":"Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation","volume":"121","year":"2013","journal-title":"Blood"},{"key":"key\n\t\t\t\t20171115102728_CIT0015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/infdis\/jix203","article-title":"Characterizing the cellular immune response to parainfluenza virus 3","volume":"216","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171115102728_CIT0016","first-page":"153","article-title":"Parainfluenza virus 3-specific T cells: opportunity for intervention?","volume":"216","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171115102728_CIT0017","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1182\/blood-2016-10-748426","article-title":"The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality","volume":"129","year":"2017","journal-title":"Blood"},{"key":"key\n\t\t\t\t20171115102728_CIT0018","article-title":"Co-infections by double-stranded DNA (dsDNA) viruses after Ex vivo T-cell depleted, CD34+ selected hematopoietic cell transplantation (HCT) [manuscript published online ahead of print 28 June 2017]","year":"2017","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/216\/8\/926\/21784624\/jix360.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T15:27:53Z","timestamp":1510759673000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jid\/article\/216\/8\/926\/4210024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,23]]},"references-count":18,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,9,23]]},"published-print":{"date-parts":[[2017,11,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jix360","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,10,15]]},"published":{"date-parts":[[2017,9,23]]}}}